Hiroshi Imamura

9.7k total citations · 1 hit paper
195 papers, 6.9k citations indexed

About

Hiroshi Imamura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hiroshi Imamura has authored 195 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Pulmonary and Respiratory Medicine, 70 papers in Oncology and 68 papers in Surgery. Recurrent topics in Hiroshi Imamura's work include Gastric Cancer Management and Outcomes (91 papers), Metastasis and carcinoma case studies (41 papers) and Colorectal Cancer Treatments and Studies (33 papers). Hiroshi Imamura is often cited by papers focused on Gastric Cancer Management and Outcomes (91 papers), Metastasis and carcinoma case studies (41 papers) and Colorectal Cancer Treatments and Studies (33 papers). Hiroshi Imamura collaborates with scholars based in Japan, United States and Belgium. Hiroshi Imamura's co-authors include Mitsuru Sasako, Hiroshi Furukawa, Shinichi Sakuramoto, Atsushi Nashimoto, Toshiharu Yamaguchi, Masashi Fujii, Toshifusa Nakajima, Taira Kinoshitá, Akira Kurita and Yasuo Ohashi and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hiroshi Imamura

171 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine

2007 1.9k citations Shinichi Sakuramoto, Mitsuru Sasako et al. profile →

Peers

Countries citing papers authored by Hiroshi Imamura

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Imamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Imamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Imamura more than expected).

Fields of papers citing papers by Hiroshi Imamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Imamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Imamura. The network helps show where Hiroshi Imamura may publish in the future.

Co-authorship network of co-authors of Hiroshi Imamura

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Imamura. A scholar is included among the top collaborators of Hiroshi Imamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Imamura. Hiroshi Imamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospective single-arm multicenter interventional study of surgical resection for liver metastasis from gastric cancer; 3-year overall and recurrence-free survival 2024 ·European Journal of Cancer ·Kazumasa Fujitani, Yukinori Kurokawa, (unknown), Atsushi Takeno, Ryohei Kawabata, Takeshi Omori, Hiroshi Imamura, Motohiro Hirao, Shunji Endo, Junji Kawada, Jeong Ho Moon, Shuji Takiguchi, Masaki Mori, Hidetoshi Eguchi, Yuichiro� Doki	3
2	Comparison of the effects of open and laparoscopic approach on body composition in gastrectomy for gastric cancer: A propensity score‐matched study 2023 ·Annals of Gastroenterological Surgery ·Tomohira Takeoka, Kazuyoshi Yamamoto, Yukinori Kurokawa, Yasuhiro Miyazaki, Ryohei Kawabata, Takeshi Omori, Hiroshi Imamura, Junya Fujita, Hidetoshi Eguchi, Yuichiro� Doki	4
3	Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial 2021 ·Gastric Cancer ·Yasuhiro Miyazaki, Takeshi Omori, Kazumasa Fujitani, Junya Fujita, Ryohei Kawabata, Hiroshi Imamura, Kazuyuki Okada, (unknown), Motohiro Hirao, Jin Matsuyama, Takuro Saito, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro� Doki	38
4	Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer 2019 ·Cancer Science ·Yasuhide Yamada, Wasaburo Koizumi, Kazuhiro Nishikawa, Masahiro Gotoh, Nozomu Fuse, Naotoshi Sugimoto, Tomohiro Nishina, Kenji Amagai, Keisho Chìn, Yasumasa Niwa, Akihito Tsuji, Hiroshi Imamura, Masahiro Tsuda, Hirofumi Yasui, Hirofumi Fujii, Kensei Yamaguchi, Hisateru Yasui, Shuichi Hironaka, Ken Shimada, Ichinosuke Hyodo	12
5	Surgical Apgar score for predicting complications after hepatectomy for hepatocellular carcinoma 2017 ·Journal of Surgical Research ·Yoshito Tomimaru, Koji Takada, Toru Shirakawa, Kozo Noguchi, Shunji Morita, Hiroshi Imamura, Takashi Iwazawa, Keizo Dono	10
6	Effects of an Oral Elemental Nutritional Supplement on Post-gastrectomy Body Weight Loss in Gastric Cancer Patients: A Randomized Controlled Clinical Trial 2016 ·Annals of Surgical Oncology ·Hiroshi Imamura, Kazuhiro Nishikawa, Kentaro Kishi, Kentaro Inoue, Jin Matsuyama, Yusuke Akamaru, Yutaka Kimura, Shigeyuki Tamura, Ryohei Kawabata, Junji Kawada, Yoshiyuki Fujiwara, (unknown), (unknown), Mari Takagi, Atsushi Takeno, Toshio Shimokawa	68
7	A Case of Carcinosarcoma of the Stomach : Small Cell Carcinoma with Rhabdomyosarcomatous Components 2013 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Kohei Okamoto, (unknown), Hiroshi Imamura, Takashi Iwazawa, Keizo Dono, (unknown), Shiro Adachi	2
8	Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer 2012 ·Clinical Cancer Research ·Masanori Terashima, Koji Kitada, Atsushi Ochiai, Wataru Ichikawa, Issei Kurahashi, Shinichi Sakuramoto, Hitoshi Katai, Takeshi Sano, Hiroshi Imamura, Mitsuru Sasako, (unknown)	185
9	Hemodynamic Analysis Of Parafoveal Capillaries Using AOSLO 2011 ·Investigative Ophthalmology & Visual Science ·Akihito Uji, Masanori Hangai, Sotaro Ooto, Nagahisa Yoshimura, Hiroshi Imamura	1
10	Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer 2011 ·European Journal of Surgical Oncology ·Kentaro Inoue, Y Nakane, Masafumi Kogire, Kazumasa Fujitani, Yutaka Kimura, Hiroshi Imamura, Shigeyuki Tamura, Shinji Okano, A.-H. Kwon, Yukinori Kurokawa, Toshio Shimokawa, Hiroya Takiuchi, Toshimasa Tsujinaka, Hiroshi Furukawa	32
11	Pharmacokinetics of TS-1 Administered Through Jejunostomy for Unresectable advanced Remnant Gastric Cancer 2010 ·The Japanese Journal of Gastroenterological Surgery ·Yasuhiro Miyazaki, Hiroshi Imamura, Hiroshi Furukawa, Masayuki Tatsuta, (unknown), (unknown), Hiroyuki Yasui	0
12	Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma 2010 ·World Journal of Gastrointestinal Oncology ·Hironori Shigeoka, Haruhiko Imamoto, Yasumasa Nishimura, Taro Shimono, Hiroshi Furukawa, Hiroshi Imamura, Takushi Yasuda, Hitoshi Shiozaki	4
13	Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG 0302) 2008 ·Japanese Journal of Clinical Oncology ·Hiroya Takiuchi, Masanori Goto, Hiroshi Imamura, (unknown), Motohiro Imano, Haruhiko Imamoto, (unknown), Hiroyasu Ishida, Kazumasa Fujitani, (unknown), T Shimokawa	24
14	The Relationship between the Number of Metastatic Lymph Nodes and Prognosis of Patients with Dukes C Colon Cancer 2002 ·The Japanese Journal of Gastroenterological Surgery ·Hideyuki Ishida, Hiroshi Furukawa, Masayuki Tatsuta, Seizo Masutani, Hiroshi Imamura, Junzo Shimizu, Norikazu Masuda, Koji Ezumi, (unknown), (unknown)	2
15	Poor prognosis associated with thrombocytosis in patients with gastric cancer 2002 ·Annals of Surgical Oncology ·Masataka Ikeda, Hiroshi Furukawa, Hiroshi Imamura, J Shimizu, Hideyuki Ishida, Seizo Masutani, Masayuki Tatsuta, Takashi SATOMI	248
16	The role of surgery in the current treatment of gastric carcinoma 2002 ·Gastric Cancer ·Hiroshi Furukawa, Hiroshi Imamura, Yasuhiro Kodera	25
17	Interactions of Drebrin and Gephyrin with Profilin 1998 ·Biochemical and Biophysical Research Communications ·Akiko Mammoto, Takuya Sasaki, Takeshi Asakura, Ikuko Hotta, Hiroshi Imamura, Kazuo Takahashi, Yoshiharu Matsuura, Tomoaki Shirao, Yoshimi Takai	119
18	MIB1‐determined Proliferative Activity in Intraductal Components and Prognosis of Invasive Ductal Breast Carcinoma 1997 ·Japanese Journal of Cancer Research ·Hiroshi Imamura, (unknown), Tadao Shimizu, Osamu Watanabe, Tetsuro Kajiwara, Motohiko Aiba	5
19	Acute Presynaptic Inhibition by Doxorubicin of Negative Chrono- and Inotropic Responses to Parasympathetic Nerve Stimulation in Isolated, Blood-Perfused Dog Atrium 1996 ·Journal of Cardiovascular Pharmacology ·(unknown), Yasuyuki Furukawa, Takeshi Oguchi, (unknown), Hiroshi Imamura, Shigetoshi Chiba	5
20	Design and application of hydraulic screw-down systems for a tandem cold mill at Kakogawa works. 1981 ·(unknown), Hiroshi Imamura, Masami Konishi, Shinya Ito	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact